StratDeckABBV

AbbVie Inc.

ABBV✓
Share

Healthcare · Drug Manufacturers - General · United States

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Price261.77USD
1D+1.81%
Market cap463B
AnalystsBuy29
Next earnings29 Oct
Loading chart…

Trade ideas

ABBV isn't in any strategy's Top Picks or Good Opportunities today.

Analysts

ConsensusBuy29
Mean score1.68
Mean target277.31+5.94%
Target range200.00–328.00

Value vs sector peers

#16 of 26 in HealthcarePaying up for quality41
  • Fwd P/E16.148
  • Yield2.7%57
  • P/E73.74
  • Rev growth+10.2%70

Not scored on P/B. The rest were reweighted to make up the difference.

Nearest in Healthcare

  1. #14AMGNAmgen Inc.Paying up for quality44
  2. #15RO.SWRoche Holding AGWeakest in sector42
  3. #16ABBVAbbVie Inc.Paying up for quality41
  4. #17SYKStryker CorporationPaying up for quality41

Fundamentals

P/E73.7
Forward P/E16.1
Price / book-77.93
Dividend yield2.69%
Beta0.28
52-week range190.75–267.4793/100
ADV (USD)1.13B
Relative volume1.1
10d avg volume4.27M
Revenue growth+10.20%
EPS growth+290.40%

Performance

1D+1.81%
7D+2.07%
1M+4.93%
3M+18.97%
6M+20.04%
YTD+17.27%

In the briefing and the feed

Briefing for 15 Sept

Neither the briefing nor the research feed has named ABBV.

Catalysts

Next earnings: 29 Oct

Trade idea history

No trade idea has fired on ABBV since the ledger opened.

Get it by email

The board ABBV sits on, in one five-minute email every weekday before the New York open and on Saturdays: market strength, the biggest movers, earnings coming up and the names sitting at their 200-day EMA.